Vicore Pharma Holding Balance Sheet Health
Financial Health criteria checks 6/6
Vicore Pharma Holding has a total shareholder equity of SEK488.8M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK540.7M and SEK51.8M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
Interest coverage ratio | n/a |
Cash | SEK 512.17m |
Equity | SEK 488.83m |
Total liabilities | SEK 51.83m |
Total assets | SEK 540.66m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 6Y4's short term assets (SEK539.3M) exceed its short term liabilities (SEK50.2M).
Long Term Liabilities: 6Y4's short term assets (SEK539.3M) exceed its long term liabilities (SEK1.6M).
Debt to Equity History and Analysis
Debt Level: 6Y4 is debt free.
Reducing Debt: 6Y4 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6Y4 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 6Y4 has sufficient cash runway for 2.6 years if free cash flow continues to reduce at historical rates of 31.1% each year.